Activity of temocillin against third-generation cephalosporin-resistant Escherichia coli and Klebsiella pneumoniae bloodstream isolates from a clinical trial.
Adam G StewartAndrew HendersonMichelle J BauerDavid L PatersonPatrick N A HarrisPublished in: JAC-antimicrobial resistance (2021)
activity against ceftriaxone-resistant Enterobacterales bloodstream isolates and may be a suitable agent to be trialled for treatment of serious infections due to these organisms.